ClinicalTrials.gg
Drug

Recombinant human nerve growth factor clinical trials

Also written rhNGF.

studies test it
11
open now
0
in phase 3
0
first study started
2012

How each study uses recombinant human nerve growth factor is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

cenegermin
4
Recombinant Human Nerve Growth Factor
3
rhNGF 10 μg/mL
2
rhNGF 20 μg/ml
2
rhNGF 180 µg/ml eye drops solution
2

Other names

rhNGF
2

Studies by the year they started

11 studies that test it; most in 2014 (2)

Studies that test recombinant human nerve growth factor, by start year
YearStudies
20121
20131
20142
20152
20161
20171
20181
20191
20241

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
8

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 10 · Other 1

Dompé Farmaceutici S.p.A (10) · Ospedale San Raffaele (1)

Studies

Open first, then newest update. How each study uses recombinant human nerve growth factor is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 11